Skip to Content
Not all colorectal cancer treatments are the same. Find out more >

Medications for Acromegaly

What is Acromegaly:  Acromegaly is a chronic metabolic disorder caused by the presence of too much growth hormone. It results in gradual enlargement of body tissues including the bones of the face, jaw, hands, feet, and skull.

Compare drugs associated with Acromegaly

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
Somavert Rx B N 1 review Add

Generic name: pegvisomant systemic

Drug class: growth hormone receptor blockers

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Sandostatin LAR Depot Rx B N Add review Add

Generic name: octreotide systemic

Drug class: somatostatin and somatostatin analogs

For consumers: dosage, interactions, side effects

 
bromocriptine Rx B N X Add review Add

Generic name: bromocriptine systemic

Brand name:  Parlodel

Drug class: dopaminergic antiparkinsonism agents, prolactin inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Parlodel Rx B N X Add review Add

Generic name: bromocriptine systemic

Drug class: dopaminergic antiparkinsonism agents, prolactin inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Somatuline Depot Rx C N Add review Add

Generic name: lanreotide systemic

Drug class: somatostatin and somatostatin analogs

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Sandostatin Rx B N Add review Add

Generic name: octreotide systemic

Drug class: somatostatin and somatostatin analogs

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
pegvisomant Rx B N 1 review Add

Generic name: pegvisomant systemic

Brand name:  Somavert

Drug class: growth hormone receptor blockers

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
octreotide Rx B N Add review Add

Generic name: octreotide systemic

Brand names:  Sandostatin LAR Depot, Sandostatin

Drug class: somatostatin and somatostatin analogs

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
lanreotide Rx C N Add review Add

Generic name: lanreotide systemic

Brand name:  Somatuline Depot

Drug class: somatostatin and somatostatin analogs

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Signifor LAR Rx C N Add review Add

Generic name: pasireotide systemic

Drug class: somatostatin and somatostatin analogs

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
pasireotide Rx C N Add review Add

Generic name: pasireotide systemic

Brand name:  Signifor LAR

Drug class: somatostatin and somatostatin analogs

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 

Learn more about Acromegaly

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hide